Thiamine supports energy, nerve, and heart function. Strongest evidence is preventing and reversing deficiency when alcohol, surgery, diuretics, or gut disease raise risk. Well-nourished adults show selective signals for fatigue, menstrual pain, and early nerve or memory findings. Oral risk is low; rare severe allergy is mainly with injections. Best for restoring levels plus targeted trials, not a longevity drug. (Full Review)

Protocol

Dose

50–100 mg oral

Thiamine HCl or mononitrate once or twice daily for low status or high-risk lifestyles

High-dose / form

600–1800 mg/day or benfotiamine 150–600 mg

Fatigue-style ~4 weeks (weight/sex-banded); benfotiamine with meals for nerve or experimental cognitive use

Timing

With meals; split high doses

Morning or carbohydrate-containing meals; split multi-hundred mg doses due to short free-thiamine half-life

Time to effect

Deficiency rescue

Hours to days

Parenteral repletion; acute neurologic signs begin to reverse early

Fatigue

~4 weeks

High-dose oral courses in inflammatory bowel disease fatigue trials

Cognitive signals

Up to 12 months

Benfotiamine mild cognitive research timelines; cardiac and glycemic often little change

Benefits

High: Prevention and reversal of clinical thiamine deficiency

Medium: Primary menstrual pain relief; high-dose oral thiamine for fatigue in quiet inflammatory bowel disease; benfotiamine signals in diabetic nerve damage

Low: Heart failure function and outcomes; cognitive decline and mild Alzheimer disease with benfotiamine

Speculative: Longevity and advanced glycation-related tissue aging in replete adults; exercise-induced fatigue in athletes; endothelial function under acute high blood sugar

Contraindications

Prior anaphylaxis to parenteral thiamine (same route/formulation without specialist evaluation)

Product-specific allergy to excipients in a given brand

Key Interactions

Loop diuretics (furosemide, bumetanide, torsemide)

Fluorouracil and some chemotherapy

Alcohol

Aspirin (high dose)

Magnesium deficiency

IV glucose without thiamine in deficiency risk

Risk & Side Effects

High: Anaphylaxis and severe hypersensitivity with parenteral use

Medium: Gastrointestinal upset at high oral doses

Low: Transient laboratory changes with benfotiamine; injection-site and infusion reactions

Speculative: Theoretical overstimulation or sleep change at very high doses

Monitoring

Marker	Target	Why
Whole-blood thiamine diphosphate (TDP)	Lab-specific; mid-to-upper reference or above deficiency cutoffs	Direct coenzyme store
Erythrocyte transketolase activity / TPP effect	Low TPP effect (often <15–20% stimulation)	Functional enzyme activity
Serum/plasma magnesium	Often ~2.0–2.5 mg/dL (functional targets vary)	Cofactor for thiamine enzymes
HbA1c (if diabetes / metabolic focus)	Individualized; many longevity clinics target ≤5.6–5.8% if safe	Context for thiamine demand
ALT (if high-dose benfotiamine)	Within lab reference; investigate sustained rises	Spot mild enzyme changes seen in some trials

Cadence: Recheck whole-blood TDP at 4–8 weeks after starting or changing dose, then every 6–12 months if continued; sooner with new diuretics, alcohol relapse, vomiting, or neurologic symptoms

Qualitative Assessment

Morning energy and afternoon crash patterns
Neuropathic tingling, pain, or vibration sense changes
Cognitive clarity and word-finding
Heart-failure symptoms if relevant (dyspnea, edema)
Gastrointestinal tolerance of the chosen dose and form

Thiamine for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment